SRRK Stock Analysis: Buy, Sell, or Hold?
SRRK - Scholar Rock Holding Corporation Common Stock
$56.50
1.25 (2.26%)
▲
5d:
+7.58%
30d:
+14.19%
90d:
+18.4%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When SRRK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: SRRK shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: SRRK shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: SRRK is currently trading at $56.50, which is considered extended relative to its 30-day fair value range of $48.62 to $54.23.
Technical Outlook: Technically, SRRK is in a uptrend. The price is approaching resistance at $57.15. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SRRK scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $59.94 (+15.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SRRK is in a uptrend. The price is approaching resistance at $57.15. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SRRK scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $59.94 (+15.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$48.62 -
$54.23
Company Quality Score
32/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
23.7%
Protect Your Profits
Holding SRRK? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($59.94)
- WARNING: Composite score 32/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$48.62 -
$54.23
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$50.69
Resistance Level
$57.15
Current Trend
Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-20.33
Wall Street Target
$59.94
(+15.2%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: August 23, 2026 8:21 PM ET
Data refreshes hourly during market hours. Next update: 9:21 PM
Data refreshes hourly during market hours. Next update: 9:21 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SRRK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
David Hallal
SELL
30615 shares
2026-04-16
Keith Woods
SELL
10220 shares
2026-04-16
Vikas Sinha
SELL
10410 shares
2026-04-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 58 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 54 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$88 | 40 SELL |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$52 | 42 HOLD |
Advanced SRRK Option Strategies
Professional options setups generated by AI based on today's SRRK price and gamma walls.
